Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis
2025-09-10 07:01
XtalPi AI Drug Discovery Collaboration Reaches Milestone as PharmaEngine's Novel PRMT5 Inhibitor PEP08 Receives Clinical Trial Approvals
2025-09-09 20:42
Amorepacific Group Marks 80th Anniversary: Unveils New Vision Slogan "Create New Beauty"
2025-09-09 09:00
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
2025-09-08 15:49
Huadong Medicine Announces Positive Preliminary Results from a Phase Ⅰ study of HDM2005, a ROR1-Targeting ADC
2025-09-05 21:38
FUTUONING Sets Sail Commercially with First Prescriptions Across China
2025-09-05 18:12
NYSE Content Advisory: Pre-Market Update + Biotech Enveda raises $150 million to reach unicorn status
2025-09-04 21:06
Halia Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
2025-09-04 20:00
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
2025-09-03 21:15
US Food and Drug Administration (FDA) Approves Henlius and Organon's BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively
2025-09-02 21:10
Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants
2025-09-02 21:00
LOTTE BIOLOGICS establishes contract manufacturing partnership with a leading U.S. Biopharmaceutical Company
2025-09-02 08:00
CMEF 2025: Promoting Holistic and High-Quality Development of Medical and Health Industry
2025-09-01 13:06
MGI Tech and JCBio Announce Collaboration on DCS Lab Project to Advance Multi-Omics Innovation in South Korea
2025-08-29 17:29
UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress
2025-08-29 14:00
Exyte and JGC Launch "Nixyte" - New EPC Brand for High-Tech Industries in Southeast Asia
2025-08-28 10:00
ACROBiosystems and DAAN Biotherapeutics Sign Strategic MOU for the Development of Precision Immuno-Oncology Therapeutics
2025-08-28 09:54
Crescom to Showcase Musculoskeletal AI Innovations at 26th Asian Musculoskeletal Society Annual Meeting
2025-08-27 09:00
Cerecin Joins NIHR HealthTech Research Centre in Brain Health as an Industry Partner
2025-08-27 00:04
Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment
2025-08-26 14:29